drugset
drugset / Trial / NCT03493698

A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects

NCT03493698 ↗

Phase 1 Completed 17 enrolled F-star Therapeutics, Inc. PRA Health Sciences · collab
Non-randomizedSequentialOpen-labelTreatment

Summary

This is a single center, open-label, fixed sequence study to investigate the effect of multiple oral dosing of Inarigivir Soproxil and a single oral dose of Midazolam in Healthy Subjects

Timeline

Start
2018-05-07
Primary completion
2018-08-27
Completion
2018-08-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Inarigivir Unknown 400 mg Oral
Subject Midazolam Small molecule 2 mg Oral

Indications

No indication recorded.